Managing Clinical Trials and Drug Approvals in China

Andrea Charles

China is now the world’s third-largest pharmaceutical market. In this interview Stefano Accorsi, Director, International Regulatory Affairs, International Comercial Operations, Chiesi Farmaceutici S.p.A, speaks to Andrea Charles from Pharma IQ, about the changes he has witnessed in the regulatory landscape in recent years and the key issues faced when managing clinical trials and drug approvals in China. Finally Accorsi shares his predictions for healthcare developments in...
To continue reading this story get free access